Li Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Li Zhao has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Yue Wang
Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China
5 shared publicationsSong Han
Department of Neurobiology, Capital Medical University, Beijing, China
4 shared publicationsYi Yan
Department of Neurobiology, Capital Medical University, Beijing, China
4 shared publicationsZhaohui Wang
Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing, PR China
4 shared publications- Junfa Li
Department of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, Capital Medical University, Beijing 100069, China
3 shared publications Xiao Liu
Department of Neurobiology, Capital Medical University, Beijing, China
3 shared publications
Latest Publications
- Open Access
- 2 January 2026
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1)
Cognitive dysfunction in type 1 diabetes: role of TREM2 in microglial activation and Aβ pathology
Background: Cognitive dysfunction associated with type 1 diabetes (T1D) is closely linked to the accumulation of amyloid-beta (Aβ) oligomers. However, the role of microglia and their underlying molecular mechanisms in this process remain unclear. Triggering receptor expressed on myeloid cells 2 (TREM2), a microglial receptor critical for clearing neurotoxic Aβ and maintaining metabolic homeostasis, is dysfunctional in Alzheimer’s disease. Here, we investigated TREM2-mediated microglial dysfunction in diabetic neurodegeneration. Purpose: To investigate the role of TREM2-mediated microglial dysfunction in Aβ clearance and cognitive impairment in T1D. Basic procedures: A total of 204 male C57BL/6J mice, aged 6–8 weeks, were used in this study. We performed single-nucleus RNA sequencing (snRNA-seq) on 59,356 cells from the prefrontal cortex and hippocampus. Aβ pathology was evaluated by western blot, immunofluorescence and ELISA. TREM2 knockout mice and the murine microglial cell line BV2 were used to study the role of TREM2 in cognitive function and Aβ clearance. Main findings: T1D mice exhibited progressive memory deficits and prefrontal Aβ oligomer accumulation (36–50 kDa), with region-specific microglial activation. SnRNA-seq identified ten microglial subpopulations, with Trem2-enriched clusters (M1/M2/M3/M5) showing impaired phagocytosis and metabolic dysregulation. TREM2 knockout exacerbated cognitive deficits and Aβ accumulation in T1D mice. Mechanistically, TREM2 regulated microglial migration, phagocytosis of Aβ oligomers, and mitochondrial integrity under high-glucose conditions, potentially via the mTOR signaling pathway. Principle conclusions: These findings establish TREM2 as a critical regulator of microglial Aβ clearance in T1D, operating mitochondrial and phagocytic programs via mTOR and highlighting its therapeutic potential for diabetic neurodegeneration.
- 2 January 2026
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1)
Open AccessCognitive dysfunction in type 1 diabetes: role of TREM2 in microglial activation and Aβ pathology
Background: Cognitive dysfunction associated with type 1 diabetes (T1D) is closely linked to the accumulation of amyloid-beta (Aβ) oligomers. However, the role of microglia and their underlying molecular mechanisms in this process remain unclear. Triggering receptor expressed on myeloid cells 2 (TREM2), a microglial receptor critical for clearing neurotoxic Aβ and maintaining metabolic homeostasis, is dysfunctional in Alzheimer’s disease. Here, we investigated TREM2-mediated microglial dysfunction in diabetic neurodegeneration. Purpose: To investigate the role of TREM2-mediated microglial dysfunction in Aβ clearance and cognitive impairment in T1D. Basic procedures: A total of 204 male C57BL/6J mice, aged 6–8 weeks, were used in this study. We performed single-nucleus RNA sequencing (snRNA-seq) on 59,356 cells from the prefrontal cortex and hippocampus. Aβ pathology was evaluated by western blot, immunofluorescence and ELISA. TREM2 knockout mice and the murine microglial cell line BV2 were used to study the role of TREM2 in cognitive function and Aβ clearance. Main findings: T1D mice exhibited progressive memory deficits and prefrontal Aβ oligomer accumulation (36–50 kDa), with region-specific microglial activation. SnRNA-seq identified ten microglial subpopulations, with Trem2-enriched clusters (M1/M2/M3/M5) showing impaired phagocytosis and metabolic dysregulation. TREM2 knockout exacerbated cognitive deficits and Aβ accumulation in T1D mice. Mechanistically, TREM2 regulated microglial migration, phagocytosis of Aβ oligomers, and mitochondrial integrity under high-glucose conditions, potentially via the mTOR signaling pathway. Principle conclusions: These findings establish TREM2 as a critical regulator of microglial Aβ clearance in T1D, operating mitochondrial and phagocytic programs via mTOR and highlighting its therapeutic potential for diabetic neurodegeneration.
- Open Access
- 1 October 2023
- Published by Wolters Kluwer Health in Brain Circulation
- Vol. 9 (4) , 228-239
Identification of brain endothelial cell-specific genes and pathways in ischemic stroke by integrated bioinformatical analysis
BACKGROUND: Ischemic stroke (IS) is a life-threatening condition with limited treatment options; thus, finding the potential key genes for novel therapeutic targets is urgently needed. This study aimed to explore novel candidate genes and pathways of brain microvessel endothelial cells (ECs) in IS by bioinformatics analysis. MATERIALS AND METHODS: The gene expression profiles of brain tissues or brain ECs in IS mice were downloaded from the online gene expression omnibus (GEO) to obtain the differentially expressed genes (DEGs) by R software. Functional enrichment analyses were used to cluster the functions and signaling pathways of the DEGs, while DEG-associated protein–protein interaction network was performed to identify hub genes. The target microRNAs and competitive endogenous RNA networks of key hub genes were constructed by Cytoscape. RESULTS: Totally 84 DEGs were obtained from 6 brain tissue samples and 4 brain vascular EC samples both from IS mice in the datasets GSE74052 and GSE137482, with significant enrichment in immune responses, such as immune system processes and T-cell activation. Eight hub genes filtered by Cytoscape were validated by two other GEO datasets, wherein key genes of interest were verified by reverse transcription-polymerase chain reaction using an in vitro ischemic model of EC cultures. Our data indicated that AURKA and CENPF might be potential therapeutic target genes for IS, and Malat1/Snhg12/Xist-miR-297b-3p-CENPF, as well as Mir17 hg-miR-34b-3p-CENPF, might be RNA regulatory pathways to control IS progression. CONCLUSIONS: Our work identified two brain EC-specific expressed genes in IS, namely, AURKA and CENPF, as potential gene targets for IS treatment. In addition, we presented miR-297b-3p/miR-34b-3p-CENPF as the potential RNA regulatory axes to prevent pathogenesis of IS.
- 1 October 2023
- Published by Wolters Kluwer Health in Brain Circulation
- Vol. 9 (4) , 228-239
Open AccessIdentification of brain endothelial cell-specific genes and pathways in ischemic stroke by integrated bioinformatical analysis
BACKGROUND: Ischemic stroke (IS) is a life-threatening condition with limited treatment options; thus, finding the potential key genes for novel therapeutic targets is urgently needed. This study aimed to explore novel candidate genes and pathways of brain microvessel endothelial cells (ECs) in IS by bioinformatics analysis. MATERIALS AND METHODS: The gene expression profiles of brain tissues or brain ECs in IS mice were downloaded from the online gene expression omnibus (GEO) to obtain the differentially expressed genes (DEGs) by R software. Functional enrichment analyses were used to cluster the functions and signaling pathways of the DEGs, while DEG-associated protein–protein interaction network was performed to identify hub genes. The target microRNAs and competitive endogenous RNA networks of key hub genes were constructed by Cytoscape. RESULTS: Totally 84 DEGs were obtained from 6 brain tissue samples and 4 brain vascular EC samples both from IS mice in the datasets GSE74052 and GSE137482, with significant enrichment in immune responses, such as immune system processes and T-cell activation. Eight hub genes filtered by Cytoscape were validated by two other GEO datasets, wherein key genes of interest were verified by reverse transcription-polymerase chain reaction using an in vitro ischemic model of EC cultures. Our data indicated that AURKA and CENPF might be potential therapeutic target genes for IS, and Malat1/Snhg12/Xist-miR-297b-3p-CENPF, as well as Mir17 hg-miR-34b-3p-CENPF, might be RNA regulatory pathways to control IS progression. CONCLUSIONS: Our work identified two brain EC-specific expressed genes in IS, namely, AURKA and CENPF, as potential gene targets for IS treatment. In addition, we presented miR-297b-3p/miR-34b-3p-CENPF as the potential RNA regulatory axes to prevent pathogenesis of IS.
- 7 April 2023
- Published by Elsevier in Life Sciences
- Vol. 325, 121686
Mitochondrial pyruvate carrier 1 alleviates hypoxic-ischemic brain injury in rats
- 7 April 2023
- Published by Elsevier in Life Sciences
- Vol. 325, 121686
Mitochondrial pyruvate carrier 1 alleviates hypoxic-ischemic brain injury in rats
- 21 May 2022
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 38 (10) , 1153-1169
cPKCγ Deficiency Exacerbates Autophagy Impairment and Hyperphosphorylated Tau Buildup through the AMPK/mTOR Pathway in Mice with Type 1 Diabetes Mellitus
Type 1 diabetes mellitus (T1DM)-induced cognitive dysfunction is common, but its underlying mechanisms are still poorly understood. In this study, we found that knockout of conventional protein kinase C (cPKC)γ significantly increased the phosphorylation of Tau at Ser214 and neurofibrillary tangles, but did not affect the activities of GSK-3β and PP2A in the hippocampal neurons of T1DM mice. cPKCγ deficiency significantly decreased the level of autophagy in the hippocampal neurons of T1DM mice. Activation of autophagy greatly alleviated the cognitive impairment induced by cPKCγ deficiency in T1DM mice. Moreover, cPKCγ deficiency reduced the AMPK phosphorylation levels and increased the phosphorylation levels of mTOR in vivo and in vitro. The high glucose-induced Tau phosphorylation at Ser214 was further increased by the autophagy inhibitor and was significantly decreased by an mTOR inhibitor. In conclusion, these results indicated that cPKCγ promotes autophagy through the AMPK/mTOR signaling pathway, thus reducing the level of phosphorylated Tau at Ser214 and neurofibrillary tangles.
- 21 May 2022
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 38 (10) , 1153-1169
cPKCγ Deficiency Exacerbates Autophagy Impairment and Hyperphosphorylated Tau Buildup through the AMPK/mTOR Pathway in Mice with Type 1 Diabetes Mellitus
Type 1 diabetes mellitus (T1DM)-induced cognitive dysfunction is common, but its underlying mechanisms are still poorly understood. In this study, we found that knockout of conventional protein kinase C (cPKC)γ significantly increased the phosphorylation of Tau at Ser214 and neurofibrillary tangles, but did not affect the activities of GSK-3β and PP2A in the hippocampal neurons of T1DM mice. cPKCγ deficiency significantly decreased the level of autophagy in the hippocampal neurons of T1DM mice. Activation of autophagy greatly alleviated the cognitive impairment induced by cPKCγ deficiency in T1DM mice. Moreover, cPKCγ deficiency reduced the AMPK phosphorylation levels and increased the phosphorylation levels of mTOR in vivo and in vitro. The high glucose-induced Tau phosphorylation at Ser214 was further increased by the autophagy inhibitor and was significantly decreased by an mTOR inhibitor. In conclusion, these results indicated that cPKCγ promotes autophagy through the AMPK/mTOR signaling pathway, thus reducing the level of phosphorylated Tau at Ser214 and neurofibrillary tangles.
- 14 May 2022
- Published by Elsevier in Brain Research Bulletin
- Vol. 185, 193-202
Downregulation of mitochondrial pyruvate carrier 2 aggravates neuronal injury in the cortex following cerebral ischemia in rat
- 14 May 2022
- Published by Elsevier in Brain Research Bulletin
- Vol. 185, 193-202
Downregulation of mitochondrial pyruvate carrier 2 aggravates neuronal injury in the cortex following cerebral ischemia in rat
- 25 February 2021
- Vol. 73 (1) , 10-16
[Changes in microglia number and Iba1 expression level in the prefrontal cortex of type 1 diabetic mice].
The aim of the present study was to observe the activation of microglia in the prefrontal cortex of type 1 diabetes mellitus (T1DM) mice, and the expression of the marker genes of the disease-associated microglia (DAM) associated with neurodegenerative diseases. Sixty healthy adult male C57BL/6J mice were randomly divided into two groups, normal control (CON) group and T1DM group. Streptozocin (STZ) was injected intraperitoneally to induce T1DM mice. The spatial learning and memory function of mice was detected by Morris water maze at the 8th week after the successful model establishment. The number and activation of microglia in the prefrontal cortex of mice were detected by immunofluorescence staining and Western blot. Changes in the mRNA level of several DAM molecular markers were detected by RT-FQ-PCR. The results showed that, compared with CON mice, the fasting blood glucose of T1DM mice increased significantly, while the body weight of T1DM mice decreased remarkably (P < 0.05). The escape latency of water maze in T1DM mice was longer than that in CON mice (P < 0.05). Compared with CON group, the Iba1 protein expression and the number of microglia in prefrontal cortex of T1DM group increased significantly (P < 0.05). In addition, the mRNA levels of several DAM markers in prefrontal cortex of T1DM group were increased significantly (P < 0.05). These results suggest that the microglia are activated and transformed to DAM type in the prefrontal cortex of T1DM mice.
- 25 February 2021
- Vol. 73 (1) , 10-16
[Changes in microglia number and Iba1 expression level in the prefrontal cortex of type 1 diabetic mice].
The aim of the present study was to observe the activation of microglia in the prefrontal cortex of type 1 diabetes mellitus (T1DM) mice, and the expression of the marker genes of the disease-associated microglia (DAM) associated with neurodegenerative diseases. Sixty healthy adult male C57BL/6J mice were randomly divided into two groups, normal control (CON) group and T1DM group. Streptozocin (STZ) was injected intraperitoneally to induce T1DM mice. The spatial learning and memory function of mice was detected by Morris water maze at the 8th week after the successful model establishment. The number and activation of microglia in the prefrontal cortex of mice were detected by immunofluorescence staining and Western blot. Changes in the mRNA level of several DAM molecular markers were detected by RT-FQ-PCR. The results showed that, compared with CON mice, the fasting blood glucose of T1DM mice increased significantly, while the body weight of T1DM mice decreased remarkably (P < 0.05). The escape latency of water maze in T1DM mice was longer than that in CON mice (P < 0.05). Compared with CON group, the Iba1 protein expression and the number of microglia in prefrontal cortex of T1DM group increased significantly (P < 0.05). In addition, the mRNA levels of several DAM markers in prefrontal cortex of T1DM group were increased significantly (P < 0.05). These results suggest that the microglia are activated and transformed to DAM type in the prefrontal cortex of T1DM mice.
- Open Access
- 1 June 2020
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 10 (3) , 512-519
Revascularization versus drug therapy for coronary artery disease in patients aged over 80 years: a real-world study
Background: Revascularization for the treatment of coronary artery disease (CAD) is advancing rapidly and is used increasingly in old patients. This study aimed to compare the efficacy and safety of revascularization with drug therapy in CAD patients aged over 80 years at a real-world clinical setting. Methods: A total of 519 CAD patients aged over 80 years were consecutively enrolled from January 2010 to January 2016 in Anzhen Hospital (Beijing, China), Capital Medical University. The patients were treated with percutaneous coronary intervention (PCI) (n=292), coronary artery bypass grafting (CABG) (n=110), or drug therapy (n=117). All-cause mortality, cardiovascular-related mortality, readmission rate, and Seattle Angina Questionnaire (SAQ) score were compared between the three treatment methods. Results: A total of 417 patients (81.9%) were followed with a median duration of 25 months. All-cause mortality and cardiovascular-related mortality in the drug therapy group were significantly higher than the PCI and CABG groups (both PConclusions: Revascularization is superior to drug therapy in efficacy and safety in the treatment of oldest-old patients with CAD.
- 1 June 2020
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 10 (3) , 512-519
Open AccessRevascularization versus drug therapy for coronary artery disease in patients aged over 80 years: a real-world study
Background: Revascularization for the treatment of coronary artery disease (CAD) is advancing rapidly and is used increasingly in old patients. This study aimed to compare the efficacy and safety of revascularization with drug therapy in CAD patients aged over 80 years at a real-world clinical setting. Methods: A total of 519 CAD patients aged over 80 years were consecutively enrolled from January 2010 to January 2016 in Anzhen Hospital (Beijing, China), Capital Medical University. The patients were treated with percutaneous coronary intervention (PCI) (n=292), coronary artery bypass grafting (CABG) (n=110), or drug therapy (n=117). All-cause mortality, cardiovascular-related mortality, readmission rate, and Seattle Angina Questionnaire (SAQ) score were compared between the three treatment methods. Results: A total of 417 patients (81.9%) were followed with a median duration of 25 months. All-cause mortality and cardiovascular-related mortality in the drug therapy group were significantly higher than the PCI and CABG groups (both PConclusions: Revascularization is superior to drug therapy in efficacy and safety in the treatment of oldest-old patients with CAD.
- Open Access
- 12 February 2020
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (2)
Intracranial Epstein–Barr virus infection appearing as an unusual case of meningitis in an immunocompetent woman: a case report
Epstein–Barr virus (EBV) is a member of the herpesvirus family, which infects most of the world’s population. EBV infection usually occurs asymptomatically. However, there are subsets of the population, such as juveniles and immunocompromised patients, among whom EBV may manifest symptomatically. In some cases, symptomatology involves the central nervous system. One such manifestation of EBV is meningitis. We report a unique case of EBV infectious meningitis in an immunocompetent adult female patient who showed unconventional clinical features. These features included afternoon fever, high intracranial pressure, low cerebrospinal fluid glucose levels, and an absence of blood monocytosis. Because this case involved a unique symptomatology, our findings broaden the symptom profile of EBV infection as presently understood.
- 12 February 2020
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (2)
Open AccessIntracranial Epstein–Barr virus infection appearing as an unusual case of meningitis in an immunocompetent woman: a case report
Epstein–Barr virus (EBV) is a member of the herpesvirus family, which infects most of the world’s population. EBV infection usually occurs asymptomatically. However, there are subsets of the population, such as juveniles and immunocompromised patients, among whom EBV may manifest symptomatically. In some cases, symptomatology involves the central nervous system. One such manifestation of EBV is meningitis. We report a unique case of EBV infectious meningitis in an immunocompetent adult female patient who showed unconventional clinical features. These features included afternoon fever, high intracranial pressure, low cerebrospinal fluid glucose levels, and an absence of blood monocytosis. Because this case involved a unique symptomatology, our findings broaden the symptom profile of EBV infection as presently understood.
- Open Access
- 18 March 2018
- Published by Wiley in Journal of Diabetes Research
- Vol. 2018, 1-9
Identification of Protein Kinase C Isoforms Involved in Type 1 Diabetic Encephalopathy in Mice
Diabetic encephalopathy is a complication of diabetes mellitus characterized by impaired cognitive functions. Protein kinase C (PKC) isoforms are rarely reported on diabetic encephalopathy, although they have been believed to play crucial roles in other diabetic complications. In this study, streptozotocin- (STZ-) induced diabetic mice were found to exhibit learning and memory deficits in the Morris water maze test. Meanwhile, the expression of cPKCβII, nPKCε, and cPKCγdid not change in the hippocampus, cortex, and striatum at 2 and 8 weeks after STZ injection. The nPKCεtranslocation to the membrane, where it is activated, was not altered in the above brain regions at 2 and 8 weeks after STZ injection. Nevertheless, cPKCβII translocation to the membrane was significantly decreased in the cortex and hippocampus at 8 weeks after STZ injection. The translocation of cPKCγfrom the cytosol to the membrane was remarkably decreased in the hippocampus at 2 and 8 weeks and in the cortex and striatum at 8 weeks after STZ injection. In addition, deletion of cPKCγaggravated the impairment of spatial learning and memory. In conclusion, our results suggest that the decrease in the activity of cPKCβII and cPKCγ, especially cPKCγ, may play key roles in the pathogenesis of diabetic encephalopathy.
- 18 March 2018
- Published by Wiley in Journal of Diabetes Research
- Vol. 2018, 1-9
Open AccessIdentification of Protein Kinase C Isoforms Involved in Type 1 Diabetic Encephalopathy in Mice
Diabetic encephalopathy is a complication of diabetes mellitus characterized by impaired cognitive functions. Protein kinase C (PKC) isoforms are rarely reported on diabetic encephalopathy, although they have been believed to play crucial roles in other diabetic complications. In this study, streptozotocin- (STZ-) induced diabetic mice were found to exhibit learning and memory deficits in the Morris water maze test. Meanwhile, the expression of cPKCβII, nPKCε, and cPKCγdid not change in the hippocampus, cortex, and striatum at 2 and 8 weeks after STZ injection. The nPKCεtranslocation to the membrane, where it is activated, was not altered in the above brain regions at 2 and 8 weeks after STZ injection. Nevertheless, cPKCβII translocation to the membrane was significantly decreased in the cortex and hippocampus at 8 weeks after STZ injection. The translocation of cPKCγfrom the cytosol to the membrane was remarkably decreased in the hippocampus at 2 and 8 weeks and in the cortex and striatum at 8 weeks after STZ injection. In addition, deletion of cPKCγaggravated the impairment of spatial learning and memory. In conclusion, our results suggest that the decrease in the activity of cPKCβII and cPKCγ, especially cPKCγ, may play key roles in the pathogenesis of diabetic encephalopathy.
- Open Access
- 20 July 2017
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 21 (12) , 3641-3657
cPKCγ‐mediated down‐regulation ofUCHL1 alleviates ischaemic neuronal injuries by decreasing autophagyviaERK‐mTORpathway
Stroke is one of the leading causes of death in the world, but its underlying mechanisms remain unclear. Both conventional protein kinase C (cPKC)γ and ubiquitin C‐terminal hydrolase L1 (UCHL1) are neuron‐specific proteins. In the models of 1‐hr middle cerebral artery occlusion (MCAO)/24‐hr reperfusion in mice and 1‐hr oxygen–glucose deprivation (OGD)/24‐hr reoxygenation in cortical neurons, we found thatcPKCγ gene knockout remarkably aggravated ischaemic injuries and simultaneously increased the levels of cleaved (Cl)‐caspase‐3 andLC3‐I proteolysis productLC3‐II, and the ratio ofTUNEL‐positive cells to total neurons. Moreover,cPKCγ gene knockout could increaseUCHL1 protein expressionviaelevating itsmRNAlevel regulated by the nuclear factor κB inhibitor alpha (IκB‐α)/nuclear factor κB (NF‐κB) pathway in cortical neurons. Both inhibitor and shRNAofUCHL1 significantly reduced the ratio ofLC3‐II/totalLC3, which contributed to neuronal survival after ischaemic stroke, but did not alter the level of Cl‐caspase‐3. In addition,UCHL1 shRNAreversed the effect ofcPKCγ on the phosphorylation levels ofmTORandERKrather than that ofAMPKandGSK‐3β. In conclusion, our results suggest thatcPKCγ activation alleviates ischaemic injuries of mice and cortical neurons through inhibitingUCHL1 expression, which may negatively regulate autophagy throughERK‐mTORpathway.
- 20 July 2017
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 21 (12) , 3641-3657
Open AccesscPKCγ‐mediated down‐regulation ofUCHL1 alleviates ischaemic neuronal injuries by decreasing autophagyviaERK‐mTORpathway
Stroke is one of the leading causes of death in the world, but its underlying mechanisms remain unclear. Both conventional protein kinase C (cPKC)γ and ubiquitin C‐terminal hydrolase L1 (UCHL1) are neuron‐specific proteins. In the models of 1‐hr middle cerebral artery occlusion (MCAO)/24‐hr reperfusion in mice and 1‐hr oxygen–glucose deprivation (OGD)/24‐hr reoxygenation in cortical neurons, we found thatcPKCγ gene knockout remarkably aggravated ischaemic injuries and simultaneously increased the levels of cleaved (Cl)‐caspase‐3 andLC3‐I proteolysis productLC3‐II, and the ratio ofTUNEL‐positive cells to total neurons. Moreover,cPKCγ gene knockout could increaseUCHL1 protein expressionviaelevating itsmRNAlevel regulated by the nuclear factor κB inhibitor alpha (IκB‐α)/nuclear factor κB (NF‐κB) pathway in cortical neurons. Both inhibitor and shRNAofUCHL1 significantly reduced the ratio ofLC3‐II/totalLC3, which contributed to neuronal survival after ischaemic stroke, but did not alter the level of Cl‐caspase‐3. In addition,UCHL1 shRNAreversed the effect ofcPKCγ on the phosphorylation levels ofmTORandERKrather than that ofAMPKandGSK‐3β. In conclusion, our results suggest thatcPKCγ activation alleviates ischaemic injuries of mice and cortical neurons through inhibitingUCHL1 expression, which may negatively regulate autophagy throughERK‐mTORpathway.